A detailed history of Entry Point Capital, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Entry Point Capital, LLC holds 10,400 shares of EW stock, worth $731,952. This represents 0.4% of its overall portfolio holdings.

Number of Shares
10,400
Previous 12 86566.67%
Holding current value
$731,952
Previous $1.11 Million 38.09%
% of portfolio
0.4%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$59.7 - $93.78 $620,163 - $974,186
10,388 Added 86566.67%
10,400 $686,000
Q2 2024

Aug 13, 2024

BUY
$84.3 - $94.31 $1,011 - $1,131
12 New
12 $1.11 Million
Q4 2023

Feb 14, 2024

BUY
$61.71 - $77.76 $68,991 - $86,935
1,118 New
1,118 $85.2 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $43.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Entry Point Capital, LLC Portfolio

Follow Entry Point Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Entry Point Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Entry Point Capital, LLC with notifications on news.